Improving Asthma Management

The course offers attendees an opportunity to update themselves on some of the most important aspects of asthma care including challenging diagnoses, the interpretation of T2 biomarkers, the appropriate use of biologic and non-biologic treatments and the management of several key co-morbidities. 

The course is aimed at all clinicians caring for patients with asthma, in both community and hospital settings, and across the multidisciplinary team.

04

FEBRUARY 2027

Online

9:00am - 4:35pm

Booking Status:

Open

BOOK NOW >
Improving Asthma Management
  • This one-day course will be delivered online with opportunities to ask questions throughout. The faculty are made up of Internationally recognised experts in their field from across the multidisciplinary team.

    Learning Outcomes

    After attending this course, you will be able to:

    • understand how to interpret lung function tests and T2 biomarkers to support diagnosis, assess risk, and facilitate steroid stewardship in the clinic 
    • understand when it may be appropriate to use montelukast, a macrolide, or LAMA therapy  
    • understand how to identify and approach work-related asthma as well as co-morbidities including ABPA, EGPA and laryngeal obstruction
    • understand the differences between biologic therapies, the importance of patient and exacerbation phenotyping, and how to manage patients if they become pregnant

    CPD points will be available for this course.

  • 9:00am - 9:10am Welcome & introduction
    9:10am – 09:35am Challenges in diagnosis: understanding the strengths and limitations of measuring airflow obstruction and airways hyper-responsiveness.
    9:35am – 10:00am Translating immunology to the nurse-led clinic:
    T2 biomarkers & steroid stewardship
    10:00am – 10:25am Predicting exacerbations and other learnings from big data
    10:25am – 10:35am Panel Discussion
    10:35am – 11:00am SCREEN BREAK
    11:00am – 11:25am Revisiting the evidence 1:
    Who are the right patients for montelukast?
    11:25am – 11:50am Revisiting the evidence 2:
    Who are the right patients for LAMA therapy?
    11:50am – 12:15pm Revisiting the evidence 3:
    Who are the right patients for maintenance macrolide therapy?
    12:15pm – 12:25pm Panel discussion
    12:25pm – 1:00pm LUNCH BREAK
    1:00pm - 1:25pm More than just asthma 1:
    Treating and monitoring ABPA
    1:25pm - 1:50pm More than just asthma 2:
    Laryngeal obstruction 
    1:50pm - 2:15pm More than just asthma 3:
    EGPA & Eosinophilic Pneumonia
    2:15pm - 2:40pm More than just asthma 4:
    Work-related asthma
    2:40pm – 2:50pm Panel discussion
    2:50pm – 3:05pm SCREEN BREAK
    3:05pm – 3:30pm Biologics 1:
    Severe asthma phenotypes and selecting the right biologic first-time 
    3:30pm – 3:55pm Biologics 2:
    Exacerbation phenotyping and understanding biologic failure
    3:55pm – 4:20pm Biologics 3:
    What to do in pregnancy
    4:20pm – 4:30pm Panel discussion
    4:30pm – 4:35pm Meeting summary and close

     

    Download the programme

  • Fees

    BTS Members: £200

    Non-Members: £400

    Payment options

    If you are paying for the course yourself, payment is by debit / credit card at the time of booking.

    If your employer is paying for your place, you can either pay with a card or select ‘Pay by invoice’ and send us a purchase order at least two weeks before the event. If this is not received on time, we will have to cancel your place. 

    For purchase orders or booking queries, email bookings@brit-thoracic.org.uk.  

    Read the booking conditions.

Explore more

Respiratory Futures Website

Visit Site >
Respiratory Futures Website

Thorax

Visit Site >
Thorax

BMJ Open Respiratory Research

Visit Site >
BMJ Open Respiratory Research